SCHEMBL5341854

SCHEMBL5341854

COc1ccc(S(=O)(=O)Nc2ccc(S(=O)(=O)Nc3cc(C)on3)cc2Cl)cc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
TP53 P04637 1/20 0.55
MAPT P10636 2/20 0.54
ADRA1A P35348 1/20 0.54
EDNRA P25101 2/20 0.54
POLB P06746 3/20 0.53
KEAP1 Q14145 1/20 0.53
NFE2L2 Q16236 1/20 0.53
EDNRB P24530 1/20 0.52
MAPK1 P28482 4/20 0.51
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
HPGD P15428 1/20 0.50
TSHR P16473 2/20 0.49
KDM4E B2RXH2 1/20 0.48
NSD2 O96028 1/20 0.48
GAA P10253 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
LMNA P02545 1/20 0.48
PKM P14618 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5344067 0.88 MAPT (0.58) ALDH1A1MAPTADRA1AMAPK1MEN1
SCHEMBL14484107 0.84 POLB (0.65) ALDH1A1MAPTADRA1AEDNRAPOLB
SCHEMBL23155764 0.82 ALDH1A1 (0.56) ALDH1A1MAPTADRA1AEDNRAPOLB
SCHEMBL5339369 0.78 ALDH1A1 (0.57) ALDH1A1MAPTADRA1AMEN1KMT2A
SCHEMBL23144461 0.77 CYP2C9 (0.56) ALDH1A1MAPTADRA1AEDNRAPOLB
SCHEMBL5336904 0.76 ALDH1A1 (0.68) ALDH1A1MAPTADRA1AMAPK1MEN1
SCHEMBL26376309 0.76 POLB (0.56) ALDH1A1MAPTADRA1AEDNRAPOLB
SCHEMBL6685766 0.76 POLB (0.58) ALDH1A1TP53MAPTADRA1APOLB
Sulfamethoxazole SCHEMBL3656 0.71 ALDH1A1 (1.00) ALDH1A1MAPTADRA1AEDNRAEDNRB
Sulfamethoxazole SCHEMBL6896861 0.71 ALDH1A1 (1.00) ALDH1A1MAPTADRA1AEDNRAEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 ALDH1A1 378/4885TP53 3854/4885MAPT 4512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.